Small-scale players in the syringes and cannulas market continue to demonstrate their dominance against the backdrop of strong supply chain in the domestic market and easy accessibility of raw materials. While prominent players accommodate the demand for high-quality syringes and cannulas in private healthcare facilities, small-scale players continue to address the demand arising from the local market such as small clinics, laboratories and nursing facilities. Further, different distribution methods adopted in the Needle and Syringe Program (NSP) show significant reliance on domestic manufacturers of the syringes and cannulas market.
Get Report Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2007
Syringes and cannulas are the primary medical instruments used in healthcare facilities for applications ranging from normal drug injections to complex surgeries. Increasing pool of patients and number of surgeries are driving the demand for syringes and cannulas substantially. Further, increasing incidences of chronic diseases such as diabetes and HIV epidemic have fuelled the consumption of syringes and cannulas. Owing to the indispensable nature of syringes and cannulas in the healthcare sector, multiple local manufacturers have emerged in the market to address the broadening gap between demand and supply. As healthcare facilities heavily rely on the bulk supply, manufacturers in the syringes and cannulas market supply the products in batches at an affordable costs. Although syringes and cannulas market is witnessing emergence of prefilled syringes and needle-less alternatives, owing to the essentiality and easy accessibility of syringes and cannulas, demand for syringes and cannulas is set to remain unaltered in the future.
Prominent Market Players Focus on R&D to Address Emerging Drug Delivery Challenges
Innovations in the medical technology landscape remain focused on delivering rapid and efficient drug delivery. Increasing preference for minimal invasive surgeries has, in turn, fuelled the need of improved injection mechanisms. Well-aware of these market dynamics, manufacturers in the syringes and cannulas market are investing heavily in R&D to introduce new drug delivery solutions. For instance, in 2016, BD received FDA approval for the first syringe for Humulin®R U-500 insulin, manufactured in collaboration with Eli Lilly & Company. Increasing demand for insulin injection devices such as insulin pen is another market domain where major R&D investments are projected. Huge investments are focused on insulin delivery syringes landscape where prominent players such as ADMD and HMD have made prominent strides. Hindustan Syringes & Medical Devices (HMD), one of the largest manufacturer of disposable syringes India’s first Dispovan Insulin Pen Needle.
Send an Enquiry @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2007
Needleless Connectors and Jet Injectors to Witness Gradual Penetration in Syringes and Cannulas Market
Rapid drug delivery and better outcome required for patients with chronic diseases is providing a fillip for greater investment in advanced medical technologies. Driven by the increasing preference for minimal invasion surgeries, R&D investments are focused on developing next-gen medical instruments such as needleless technologies. Needle-free jet injector delivery system is one of the trending medical technology which received first FDA approval in 2014 for PharmaJet’s injector for a flu vaccine. Further, development of needleless connectors is serving as an efficient alternative of cannulas in term of reduced microbial ingress and integrity maintenance. BD has launched several needleless connectors such as NeutraClear™, SmartSite™ and MaxZero™. CArdina Health has introduced Kendall™ needleless connector. B. Braun Melsungen AG delivers a portfolio of needleless connectors such as InVision-Plus ® IV Connector and SAFELINE® Split Septum.
Public Healthcare Initiatives Ensure Steady Growth of the Syringes and Cannulas Market
The syringes and cannulas market is projected to witness steady growth on the back of increasing emphasis on the use of disposable syringes to prevent spread of infectious disease. Initiatives such as NPS, multiple immunization programs and WHO’s use of Smart Syringes by national and international authorities to promote safe use of injections has, in turn, propelled the syringes and cannulas market. The initiatives are addresses at increasing penetration of safe use of syringes and cannulas and huge price differences between the distribution purchase and retail prices. For instance, the National Pharmaceutical Pricing Authority (NPPA) in India estimated a mark-up of 664% in retail prices of syringes in FQ 2018. Following the statistics, the Department of Pharmaceutical is expected to regulate the pricing. On the other hand, the government is expected to initiate use of auto-disable syringes to control spread of infection through disposable syringes.
Competitive Landscape
The competitive landscape section of the syringes and cannulas market report profiles key players operating in the global syringes and cannulas landscape. The section also delivers vital information such as product portfolio, notable business strategies and revenue share of key market players. Few of the profiled players in the syringes and cannulas market include Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Edwards Lifesciences Corporation, Terumo Corporation, Medtronic Plc., and Smiths Group plc (Smiths Medical).
Get Customized Research report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2007
Prominent players in the syringes and cannulas market are observed to engage in acquisition and mergers to expand their product offering and strengthen market presence. Becton, Dickinson and Company (BD), in 2017, announced the completion of acquisition of C.R.Bard Inc. The combined company is expected to witness growth in the non-U.S. market with Bard’s strong product portfolio and innovation pipeline and BD’s expertise in medication management and infection prevention. Medtronic has announced acquisition of Mazor Robotics to expand its capacity in robotic-assisted procedures in spine surgery.
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
